EPISODE · Oct 1, 2024 · 34 MIN
What's new in PAH in 2024
from The APAPP Podcast · host APAPP
Dr. Melissa Wilson discusses new treatments in the field of pulmonary hypertension in 2024, focusing on Sotatercept and combination therapy with Opsynvi. Dr. Wilson emphasizes the importance of patient selection and individualized treatment plans. She also discusses the initiation and monitoring of these therapies, as well as potential side effects and patient adherence.Send us Fan MailClaim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.comFollow us on:Instagram @pulmapps Twitter@pulmapp Facebook @association of pulmonary advance practice providers.
Embed this episode
What this episode covers
Dr. Melissa Wilson discusses new treatments in the field of pulmonary hypertension in 2024, focusing on Sotatercept and combination therapy with Opsynvi. Dr. Wilson emphasizes the importance of patient selection and individualized treatment plans. She also discusses the initiation and monitoring of these therapies, as well as potential side effects and patient adherence. Send us Fan Mail Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA Visit...
NOW PLAYING
What's new in PAH in 2024
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.